En español
NIDA

Utah Opioid Summary

Revised February 2018

Opioid-Related Overdose Deaths

In 2016, there were 466 opioid-related overdose deaths­­­ in Utah—a rate of 16.4 deaths per 100,000 persons and more than the national rate of 13.3 deaths per 100,000 persons.

This graph shows the rate of opioid-related overdose deaths in Utah compared to the United States from 1999-2016. In 2016, the opioid overdose death rate was 16.4 deaths per 100,000 persons in Utah, versus 13.3 deaths per 100,000 persons in the United States.

Opioid Pain Reliever Prescriptions

In 2015, Utah providers wrote 73.1 opioid prescriptions per 100 persons (2.2 million prescriptions). In the same year, the average U.S. rate was 70 opioid prescriptions per 100 persons (IMS Health, 2016).

This graph shows the number of opioid-related overdose deaths in Utah from 1999-2016. In 2016, there were 466 opioid-related overdose deaths: 72 involved synthetic opioids, 166 involved heroin, and 349 involved prescription opioids. Categories are not mutually exclusive because deaths may involve more than one drug.

Neonatal Abstinence Syndrome (NAS)

The incidence of NAS in Utah has increased from 0.8 cases per 1,000 births in 2000 to 4.1 cases per 1,000 births in 2011, a more than five-fold increase. The average across the 28 states included in the 2013 analysis was 6.0 cases per 1,000 births (CDC, MMWR, 2014).

HIV Prevalence and HIV Diagnoses Attributed to Injection Drug Use (IDU)

  • U.S. Incidence: In 2015, 9.1 percent (3,5941) of the 39,513 new diagnoses of HIV in the United States were attributed to IDU. Among new cases, 8.2 percent (2,6141) of cases among men and 13.2 percent (980) of cases among women were transmitted via IDU (CDC).
  • U.S. Prevalence: In 2014, 955,081 Americans were living with a diagnosed HIV infection—a rate of 299.5 per 100,000 persons. Of these, 18.1 percent (131,0561) of males and 22.6 percent (52,013) of females were living with HIV attributed to IDU (CDC).
  • State Incidence: Of the new HIV cases in 2015, 116 occurred in Utah, with 18.7 percent1 of new cases in males and 16.7 percent of new cases in females attributed to IDU (AIDSVu).
  • State Prevalence: In 2014, an estimated 2,618 persons were living with a diagnosed HIV infection in Utah—a rate of 115 infections per 100,000 persons. Of these, 24.7 percent1 of males and 27.4 percent of females were living with HIV attributed to IDU (AIDSVu).

Hepatitis C (HCV) Prevalence and HCV Diagnoses Attributed to Injection Drug Use

  • U.S. Incidence: In 2015, there were 181,871 reported cases of chronic HCV and 33,900 estimated cases of acute HCV2 (CDC). Where data were available, 64.2 percent of acute cases reported IDU (CDC).
  • U.S. Prevalence: An estimated 3.5 million Americans are living with HCV, including approximately 2.7 million living with chronic infections (CDC).
  • State Incidence: In 2014, Utah reported 35 cases of acute HCV and 1,507 cases of chronic HCV at a rate of 1.2 cases per 100,000 persons and 51.1 cases per 100,000 persons, respectively (health.utah.gov).
  • State Prevalence: As of 2010, an estimated 17,600 persons were living with HCV in Utah (HepVu).

Additional Resources

NIH RePORTER FY2017 NIH-funded projects related to opioid use and use disorder in Utah: 0

Notes

  1. Includes transmission to individuals with injection drug use as a risk factor.
  2. 2015 estimate after adjusting for under-ascertainment and under-reporting. Data for 2015 were unavailable for Alaska, Arizona, Connecticut, the District of Columbia, Hawaii, Iowa, Mississippi, New Hampshire, Rhode Island, and Wyoming.

This page was last updated February 2018

Get this Publication

Opioid Summaries by State

NIH HEAL (Helping to End Addiction Long-term) Initiative

New Opioid Overdose Materials for Patients

Easy-to-read Drug Facts

This Is NIDA: Opioids

This Is NIDA: Opioids

The National Institute on Drug Abuse's research-based, informative video series "This Is NIDA," addresses the topic of OPIOIDS.